Skip to content Skip to search Skip to footer
Washington University School of Medicine in St. Louis

Department of Neurology | Neuromuscular Medicine

Miller Laboratory

Menu
  • About
    • About the Miller Lab
    • Lab Members
    • Lab Alumni
    • Our Commitment to Diversity, Equity, and Inclusion
  • ALS Research
  • Dementia Research
  • Publications
  • News
    • News
    • ALS Center Newsletters
  • Donate
  • Work with Us
  • Contact

Category: Media

Experimental drug shows promising results for rare form of ALS (Links to an external site)

July 9, 2020October 2, 2020

Researchers led by a Washington University neurologist found promising results for an experimental drug to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease.

Research in St. Louis leads to promise in the fight against ALS (Links to an external site)

July 9, 2020October 2, 2020

ST. LOUIS – Research taking place at Washington University’s School of Medicine is giving hope to those affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

Miller Laboratory

Neuromuscular Medicine

Department of Neurology

4559 Scott Ave

St. Louis, MO 63110

Contact Us

  • Twitter

Stay Connected

Receive Miller Lab updates.

Join our Email List

Learn about our patient care services at the ALS Center.

Make A Difference

Help develop new treatments, therapies and cures.

Donate

©2023 Washington University in St. Louis